I think he's carefully worded - he says BOT do have enough money in the bank to get SB over the line (read - approved) and 'commence' commercialization, but whether BOT can sustain commercialization/manufacture/supply without another CR is another question, and he does say BOT will consider their options at that point. How much cash do you think they need to commercialize considering BOT have said they are looking to contract out production (so no capital purchases)? Maybe they can do a deal with the manufacturer that negates a CR?
- Forums
- ASX - By Stock
- BOT
- Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-97
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 96148 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 782479 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 96148 | 0.365 |
7 | 391832 | 0.360 |
5 | 284373 | 0.355 |
5 | 297700 | 0.350 |
3 | 610000 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 782479 | 9 |
0.375 | 210000 | 2 |
0.380 | 1003076 | 7 |
0.385 | 578187 | 13 |
0.390 | 653299 | 26 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |